<?xml version="1.0" encoding="UTF-8"?>
<p id="Par28">Moseley et al. reported improved survival in influenza virus-infected mice treated with AICAR and a further improved survival (by 60%) using combination therapy (AICAR + pioglitazone). The authors conclude that the results of their study provide preliminary evidence that stimulating the PPAR axis (with AICAR and PPARγ agonists) may prove to be a beneficial effect in the severe influenza infection [
 <xref ref-type="bibr" rid="CR41">41</xref>].
</p>
